Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.44M Sell
69,520
-35,886
-34% -$3.95M 0.67% 40
2026
Q1
$11.1M Sell
105,406
-10,893
-9% -$1.28M 1.4% 26
2025
Q4
$14.5M Sell
116,299
-1,827
-2% -$218K 1.66% 23
2025
Q3
$14.2M Buy
118,126
+1,631
+1% +$172K 1.94% 21
2025
Q2
$10.7M Sell
116,495
-8,350
-7% -$762K 1.4% 29
2025
Q1
$11M Hold
124,845
1.4% 26
2024
Q4
$11.6M Buy
124,845
+10,273
+9% +$989K 1.45% 27
2024
Q3
$10.6M Sell
114,572
-7,487
-6% -$629K 1.35% 29
2024
Q2
$9.15M Sell
122,059
-12,479
-9% -$996K 1.34% 28
2024
Q1
$11.6M Buy
134,538
+21,650
+19% +$1.65M 1.49% 31
2023
Q4
$7.81M Sell
112,888
-15,790
-12% -$953K 1.37% 31
2023
Q3
$7.04M Buy
+128,678
New +$7.31M 1.12% 31
2021
Q4
Sell
-15,137
Closed -$708K 79
2021
Q3
$708K Hold
15,137
0.1% 69
2021
Q2
$770K Hold
15,137
0.09% 90
2021
Q1
$711K Hold
15,137
0.11% 87
2020
Q4
$644K Buy
+15,137
New +$595K 0.11% 77

Other funds holding CRH

Aperture Investors's CRH Position: Q2 2026 in Review

Aperture Investors reduced its CRH (CRH) stake by 34% in Q2 2026, selling an estimated $3.95M and leaving 69,520 shares worth $7.44M. The position accounts for 0.67% of the portfolio, ranked #40.

Aperture Investors first reported a position in CRH in Q4 2020 and has held it in 16 quarters since. The position peaked at $14.5M in Q4 2025. 1,029 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Aperture Investors held 69,520 shares of CRH worth $7.44M as of Q2 2026.
  • Aperture Investors sold 35,886 CRH shares in Q2 2026, an estimated $3.95M.
  • CRH made up 0.67% of Aperture Investors's portfolio in Q2 2026, its #40 holding.
  • Aperture Investors first reported a position in CRH in Q4 2020 and has held it in 16 quarters since.
  • Aperture Investors's CRH position peaked at $14.5M in Q4 2025.
  • 1,029 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Aperture Investors's 13F filing for Q2 2026, filed 14 Aug 2026.